Red clover and lifestyle changes to contrast menopausal symptoms in premenopausal patients with hormone-sensitive breast cancer receiving tamoxifen.
Cristina FerrarisBarbara BallestraChiara ListortiVera CappellettiCarolina ReduzziGianfranco P ScaperrottaIolanda PuliceEleonora G A FerrariSecondo FolliLuigi MarianiGabriele MartelliPublished in: Breast cancer research and treatment (2020)
This is the first trial to assess red clover in BC patients on tamoxifen. The preparation proved safe clinically and in vitro, and was associated with reduced BMI and waist circumference, but the diet-lifestyle intervention probably improved the menopausal symptoms.
Keyphrases
- body mass index
- physical activity
- weight loss
- end stage renal disease
- ejection fraction
- randomized controlled trial
- cardiovascular disease
- newly diagnosed
- clinical trial
- chronic kidney disease
- breast cancer cells
- estrogen receptor
- prognostic factors
- body weight
- positive breast cancer
- study protocol
- sleep quality
- postmenopausal women
- weight gain
- patient reported outcomes
- type diabetes
- computed tomography
- phase ii
- young adults